Company intelligence / Profile preview

Trident Toxicology

United Statestridentbiopharmsolutions.com ↗

Ownership: Private
Development stage: Other

Overview

Trident Toxicology provides expert consulting in nonclinical safety assessment, pathology interpretation, toxicology study design and review, regulatory strategy, due diligence for licensing/investment decisions, with particular expertise in biotherapeutics. The company does not have its own clinical pipeline but supports clients' programs at all stages of preclinical and clinical development.

Modalities: BiologicSmall moleculeMonoclonal antibodyPeptides
Industry: Consulting

Partnerships

Pharmaceutical/biotech companies (as consultant/advisor)

Beyond the preview

Go deeper on Trident Toxicology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trident Toxicology.

Explore the full profile